Northerner Withdraws from Tobacco Market to Become Exclusive Retailer for Nicotine Pouches and Other ONDs

Regulations by 2FIRSTS.ai
Dec.10.2024
Northerner Withdraws from Tobacco Market to Become Exclusive Retailer for Nicotine Pouches and Other ONDs
Northerner to exclusively sell nicotine pouches and oral products starting December 2024, following declining tobacco sales trend.

According to Business Wire on December 9th, the American online nicotine product retailer Northerner announced that as of December 2024, it will exclusively sell nicotine pouches and other modern oral nicotine products.

 

Business and International Affairs Senior Director Sarah Krysalka of Northerner pointed out that,

 

After 25 years entrenched in the smokeless tobacco industry, making the decision to abandon tobacco is not easy. But the trend is clear, with more and more Americans choosing smokeless tobacco products.

 

After exiting the tobacco market, Northerner will instead meet the growing demand from consumers for nicotine pouches and other modern oral nicotine products. Our goal is to cater to the evolving needs of adult nicotine users while promoting tobacco-free nicotine alternatives to tobacco consumers.

 

According to data from the Centers for Disease Control and Prevention (CDC), tobacco sales continue to decline, while the popularity of nicotine pouches is on the rise. From 2015 to 2021, cigarette sales in the United States decreased by approximately 27%, from 12.5 billion packs to 9.1 billion packs. Meanwhile, sales of nicotine pouches and other alternative products in the U.S. doubled from $452.76 million in 2020 to $1.06 billion in 2022.

 

According to reports, Northerner is part of the Haypp Group. The company claims that since its establishment in 1998, it has grown to become one of the largest online retailers of nicotine pouches globally.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
UK to Implement e-cigarette Product Tax and Stamp Plan from October 1, 2026
UK to Implement e-cigarette Product Tax and Stamp Plan from October 1, 2026
HMRC announces e-cigarette tax stamp plan to combat illicit trade starting October 1, 2026 alongside VPD policy enforcement.
Nov.27 by 2FIRSTS.ai
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria Group and its NJOY subsidiary have filed a lawsuit in Virginia federal court challenging the U.S. International Trade Commission’s process for appointing administrative law judges. The companies allege the system violates the U.S. Constitution and seek to halt an ITC patent investigation initiated by rival Juul.
Nov.10
Scottish Retailers Urge Government to Fast-Track Nicotine Pouch Regulations
Scottish Retailers Urge Government to Fast-Track Nicotine Pouch Regulations
The Scottish Grocers’ Federation (SGF) is calling on the government to clarify the regulatory framework for nicotine pouches in order to prevent high-strength and illegal products from entering the market, stressing that these products should not be targeted at minors.
Dec.04 by 2FIRSTS.ai
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire Technology and IKE Tech issued statements after the U.S. FDA received Congressional funding and directives to strengthen enforcement against illicit vaping products. The companies emphasized updated guidance, multi-agency coordination and the role of blockchain and age-verification technologies in preventing illegal imports and protecting youth.
Nov.20
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.
Nov.24